Fay Nicolson

Looking to compare brightness between radionuclides? look no further! Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System. A collection over the years including over 23 radionuclides! @grimmrad.bsky.social and @lewislabmskcc.bsky.social
jnm.snmjournals.org/content/earl...

These are extremely challenging times for early-career faculty. Here is my office's small contribution to make their hard and important work a bit easier:

Download our curated and comprehensive database of funding opportunities for early-career faculty.

Here: research.jhu.edu/rdt/funding-...

DFCI Initiative to Study RAS-Driven Cancers Dana-Farber Cancer Institute announced the launch of the Center for RAS Therapeutics, an initiative that aims to advance new treatments for patients with RAS-mutant cancers through collaborations between researchers, industry, and other academic medical centers. RAS mutations are found in 20% of all cancers and are a major driver of certain malignancies, such as pancreatic and colorectal cancers.

@danafarber.bsky.social announced the Center for RAS Therapeutics, an initiative to advance treatments for patients with RAS-mutant cancers. Learn more at https://bit.ly/3DIgdqi

A new post in Science Careers for our open-rank faculty search at the Hunter College Dept of Biological Sciences: jobs.sciencecareers.org/job/668588/o...

SAVE THE DATE: The 4th Transatlantic Exchange in Oncology between @danafarber.bsky.social and Gustave Roussy will take place in Paris on Wednesday March 19, 2025 and will focus on Radiopharmaceuticals.

Free registration and Hybrid option!

In partnership with Servier and Medscape

2024 in Review Nature Cancer’s 2024 in Review Focus comprises news, analysis and comment articles on the most exciting advances and biggest challenges of the past year, ...

⭐️As every December don't miss our Year In Review Focus Issue featuring 2024's highlights in #cancerresearch and #oncology.

The 2024 generation Nature Cancer - Twelve early-career researchers who embarked on their independent research paths in 2024 reflect on their experience from their journey so far, describe the opportunities they...

Grateful to contribute to@natureportfolio.bsky.social @naturecancer.bsky.social Viewpoint reflecting on my 1st year as an independent investigator@danafarber.bsky.social 🧪Thanks to lab members, mentors, collaborators, friends, & family who have supported me this year! 💫 ✨ 💡 rdcu.be/d3R8r